None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Volunteers between the ages of 18 and 54 diagnosed with androgenic alopecia - Subjects who will not use special hair products or undergo hair care or manipulation during the study period - Subjects who will maintain the same hairstyle and color as at the first visit throughout the study period - Subjects who understand the purpose and content of the study and voluntarily sign the informed consent form prior to participation - Healthy subjects without acute or chronic physical diseases, including dermatological disorders - Subjects who are able to comply with follow-up observations during the study period
Exclusion criteria
Exclusion criteria: - Subjects who do not wish to participate or who have not signed the informed consent form - Subjects with severe acute renal or cardiac diseases, or other chronic diseases (e.g., hypertension, diabetes) within the last 6 months that may affect the study results - Subjects who are pregnant, breastfeeding, or planning to become pregnant within 6 months - Subjects with psychiatric disorders - Subjects with infectious skin diseases - Subjects who have undergone surgical treatments for hair loss such as hair transplantation or scalp reduction - Subjects who have taken oral dutasteride or finasteride within the last 6 months - Subjects who have applied topical hair growth or anti-hair loss agents within the past month - Subjects who have taken any of the following medications within the past month: steroids, cytotoxic agents, vasodilators, antihypertensive agents, anticonvulsants, beta-blockers, bronchodilators, diuretics, spironolactone, cimetidine, diazoxide, cyclosporine, or ketoconazole - Subjects who have applied topical steroid preparations to the scalp within the past month - Subjects deemed unsuitable for application of the investigational product due to severe seborrheic dermatitis, scalp psoriasis, or scalp infection - Subjects with other forms of alopecia besides androgenic alopecia, such as alopecia areata, telogen effluvium, or traction alopecia - Subjects with nutritional deficiencies caused by excessive dietary restrictions or gastrectomy, or those taking nutritional supplements that may affect hair loss - Any other subjects deemed unsuitable for participation by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Phototrichogram (total number of hairs within the shaved area) | — |
Secondary
| Measure | Time frame |
|---|---|
| Researcher evaluation by photography;Survey evaluation by test subjects;Anagen/Telogen ratio | — |
Countries
Korea, Republic of
Contacts
SKINMED